2009
DOI: 10.1016/j.neurobiolaging.2008.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial haplogroup H and Alzheimer's disease—Is there a connection?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
52
2

Year Published

2009
2009
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 77 publications
(57 citation statements)
references
References 49 publications
3
52
2
Order By: Relevance
“…This transition is characteristic of particular mtDNA haplogroup H subgroups (164,227). To date, some studies have found haplogroup H is relatively over-represented in AD cohorts (86,173,174,227). As a potentially related finding, haplogroup H may represent a particularly well-coupled haplogroup, which infers that individuals with haplogroup H may produce more ROS than individuals with other haplogroups (171).…”
Section: Swerdlowmentioning
confidence: 99%
“…This transition is characteristic of particular mtDNA haplogroup H subgroups (164,227). To date, some studies have found haplogroup H is relatively over-represented in AD cohorts (86,173,174,227). As a potentially related finding, haplogroup H may represent a particularly well-coupled haplogroup, which infers that individuals with haplogroup H may produce more ROS than individuals with other haplogroups (171).…”
Section: Swerdlowmentioning
confidence: 99%
“…This modulation is carried out either directly by influencing energy production efficiency (Baudouin et al 2005), or indirectly by interaction with nuclear genes (Ryan and Hoogenraad 2007). In humans, the involvement of nuclear-mitochondrial interactions in modulating complex phenotypes is supported by the observation of non-random associations between mtDNA and nuclear variability (De Benedictis et al 2000;Carrieri et al 2001;Maruszak et al 2008). In mice, by means of conplastic strains expressing different combinations of mitochondrial/nuclear genomes, it has been unequivocally demonstrated that mtDNA variability affects complex phenotypes, such as hearing loss (Johnson et al 2001), cognitive function (Robertoux et al 2003) and risk of type 2 diabetes (Pravenec et al 2007).…”
Section: Introductionmentioning
confidence: 99%
“…28,29 This means that each haplogroup, with its different set of SNPs, can have unique bioenergetic properties and responses to oxidative stressors. The risks of developing PD and AD within the Western European are higher among mtDNA haplogroup H, but lower for haplogroups J and K. 30,31 It is possible that the haplogroup H has significantly higher mitochondrial oxidative damage and higher VO (2max) (oxygen consumption) to produce more ROS. 32 It seems to be that the association between haplogroup U and the risks of sCJD needs further assays in a larger sample scale.…”
Section: Discussionmentioning
confidence: 99%